The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001381370
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
4/11/2026
Date registered
Help: Date registered
19/11/2026
Date last updated
Help: Date last updated
19/11/2026
Date data sharing statement initially provided
Help: Data sharing statement date
19/11/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Implementation of an egg ladder for children with mild Immunoglobulin E (IgE) - mediated egg allergy at the Women's and Children's Health Network (WCHN)
Scientific title
Egg Ladder at WCHN – A nurse-triaged, dietitian-led model of care for mild paediatric IgE medicated egg allergy at the Women’s and Children’s Hospital
Additional trial identifiers [1] 318783 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
IgE-mediated egg allergy 344069 0
Condition category
Condition code
Inflammatory and Immune System 340198 340198 0 0
Allergies

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Exposure: Nurse-triaged, dietitian-led model of care to deliver an egg ladder

This study evaluates the implementation of a nurse-triaged, dietitian-led model of care to deliver an egg ladder for children with mild IgE-mediated egg allergy attending the Women's and Children's Hospital (WCH). The model is delivered as part of routine clinical practice and is designed to support the safe introduction of egg-containing foods using a standardised egg ladder approach.

Following referral to the WCHN Allergy and Clinical Immunology Department, an allergy nurse reviews referrals against predefined eligibility criteria to identify children suitable for management through a dietitian-led pathway. Eligible participants will be further screened with a parent led survey and will then be referred to a dietitian with expertise in paediatric food allergy and allergy nutrition management. The dietitian provides assessment, education, counselling, and ongoing support to families regarding egg allergy management, recognition of allergic reactions, safe food introduction practices, and support with progression through the WCHN egg ladder. The dietitian will provide the WCHN egg ladder resource and the accompanying fact sheet. Participants requiring medical review because of adverse reactions, diagnostic uncertainty, or inability to progress are escalated to an allergy specialist according to standard clinical pathways (i.e. waitlist management).

Implementation of an egg ladder involves the gradual introduction of increasingly allergenic forms of egg, commencing with baked and extensively heated egg-containing foods and progressing to less cooked forms of egg as tolerated. Progression is individualised based on reported tolerance and clinical assessment.

The WCHN Egg Ladder is a resource for a graded home-based egg introduction protocol consisting of five sequential steps with increasing exposure to less extensively cooked egg. The steps are: (1) baked egg, such as muffin products; (2) well-cooked egg as an ingredient, such as pancakes; (3) well-cooked whole egg, such as hard-boiled egg; (4) lightly cooked whole egg, such as scrambled egg; and (5) pasteurised raw egg, such as egg-based mayonnaise. Families are instructed to commence at step 1 (e.g. muffin), starting with a pea size amount and over a few days or weeks, slowly increasing to an age-appropriate serve. Once at an age-appropriate serve, it is suggested participants spend at least 1-3 months in each step, before progressing to the next step. If allergic symptoms occur after progressing, families are advised to return to the previously tolerated step before re-attempting a higher step. The egg ladder is undertaken under the supervision of the treating allergy dietitian.

Participating families will also receive a written WCHN Egg Ladder ‘Frequently Asked Questions’ information sheet developed by the WCHN Allergy Service. The resource explains the purpose and rationale of the egg ladder, including how gradual introduction of increasingly less processed forms of egg may support the development of tolerance in children with mild egg allergy. The materials provide eligibility and readiness guidance for commencing the ladder, detailed instructions for progressing through each step, practical examples of suitable foods at each stage, recommended portion escalation from a pea-sized amount to an age-appropriate serve, and advice regarding the recommended frequency and duration of consumption at each step.

The information sheet also includes information on recognising and managing allergic reactions, differentiation between mild and severe reactions, instructions for responding to reactions according to the child's ASCIA Action Plan, guidance on when to pause or step back within the ladder, and advice on when urgent medical attention should be sought. Families are advised to have prescribed allergy medications and their ASCIA Action Plan available during food introductions. Frequently asked questions, safety precautions, and practical tips for implementing the egg ladder at home are also included. Verbal education is provided by the study dietitian to support understanding and application of the written materials.

The model of care will be delivered through individual consultations conducted face-to-face in the outpatient clinic and/or via telehealth, supplemented by written educational resources. The patients will be followed up at the 2-3 month mark and then at 6 months post the initial dietitian appointment, supporting the commencement of the egg ladder. The intervention is delivered through the Women's and Children's Hospital Allergy Service, with egg introduction occurring in the participant's usual home environment under parent or caregiver supervision.

Adherence is supported through scheduled follow-up appointments, review of participant progress through the egg ladder, documentation of tolerated foods and reactions, and opportunities for families to contact the service for advice. Progression through the egg ladder, reported adverse reactions, healthcare utilisation, and participant/parent experiences are collected as part of the implementation evaluation.
Intervention code [1] 335716 0
Treatment: Other
Description of the comparator or control
The control group is historical and concurrent controls (participants who do not wish to enter the dietitian-led model of care).

A historical control cohort will be identified from patients with egg allergy who attended the Women's and Children's Hospital Allergy Service in 2018 and 2019 who meet the study inclusion and exclusion criteria. These patients received standard care, consisting of management by an Allergy/Immunology specialist and dietitian according to usual clinical practice.
Control group
Historical

Outcomes
Primary outcome [1] 347347 0
Highest egg ladder step achieved (most allergenic form of egg consumed)
Timepoint [1] 347347 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Primary outcome [2] 347422 0
Amount of egg or egg-containing food product consumed at the highest step
Timepoint [2] 347422 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Primary outcome [3] 347424 0
Frequency of consumption of egg or egg-containing foods at the highest WCHN Egg Ladder step achieved
Timepoint [3] 347424 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [1] 470350 0
Proportion of participants able to follow the WCHN egg ladder as directed 'Proportion of participants able to follow the WCHN Egg Ladder as directed', will be defined as participants who have commenced the WCHN Egg Ladder and successfully progressed by at least one egg ladder step in accordance with the dietitian-recommended protocol, without permanent discontinuation of the ladder.
Timepoint [1] 470350 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [2] 470351 0
How many eligible participants agree to try the egg ladder?
Timepoint [2] 470351 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [3] 470353 0
Home reaction rate during the WCHN Egg Ladder
Timepoint [3] 470353 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [4] 470354 0
Parental food allergy-associated anxiety and coping, measured using the Impairment Measure for Parental Food Allergy-Associated Anxiety and Coping Tool (IMPAACT).
Timepoint [4] 470354 0
Baseline (prior to commencement of the WCHN Egg Ladder); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [5] 470355 0
Food frequency of other allergenic foods (peanut, tree nut, cow's milk, wheat, soy, fish, shellfish)
Timepoint [5] 470355 0
Baseline (prior to commencement of the WCHN Egg Ladder); 2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [6] 470846 0
Reaction severity during the WCHN Egg Ladder
Timepoint [6] 470846 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)
Secondary outcome [7] 470847 0
Emergency healthcare presentations related to egg or egg-containing food ingestion during the WCHN Egg Ladder
Timepoint [7] 470847 0
2–3 months following the initial dietitian appointment (egg ladder education); 6 months following the initial dietitian appointment (egg ladder education)

Eligibility
Key inclusion criteria
- Children aged 6 months to 6 years
- Referred to WCHN Allergy and Immunology Service with suspected or confirmed IgE-mediated egg allergy
- Isolated egg allergy (i.e. no other food allergies)
- Skin involvement only (urticaria, erythema, angioedema) and/or a single vomit (no respiratory or cardiovascular involvement, no requirement for treatment with adrenaline)
- Parent/guardian able to adhere to provision of food from a ladder
- Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf.
Minimum age
6 Months
Maximum age
6 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
- Prior anaphylaxis to egg or egg containing products
- Prior allergic reaction/s to food requiring treatment with adrenaline
- Multiple confirmed food allergies
- Moderate-severe eczema unresponsive to topical steroids
- Asthma on regular inhaled corticosteroids
- Perioral rash only
- Parent/guardian unable to complete the parent survey or read study materials in written English (all study documentations and intervention materials are in English)
- Parent/guardian unable to adhere to provision of food from a ladder
- Past or current medical problems or findings from physical assessment which, in the opinion of the Principal Investigator, may pose additional risks from participation in the study, may interfere with the participant’s ability to comply with study requirements, or may impact the quality or interpretation of the data obtained from the study.


Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 30498 0
Womens and Childrens Hospital - North Adelaide
Recruitment postcode(s) [1] 46927 0
5006 - North Adelaide

Funding & Sponsors
Funding source category [1] 323354 0
Government body
Name [1] 323354 0
Allied and Scientific Health Office
Country [1] 323354 0
Australia
Funding source category [2] 323387 0
Charities/Societies/Foundations
Name [2] 323387 0
The Hospital Research Foundation Group
Country [2] 323387 0
Australia
Primary sponsor type
Hospital
Name
Women's and Children's Health Network
Address
Country
Australia
Secondary sponsor category [1] 326356 0
Government body
Name [1] 326356 0
Allied and Scientific Health Office
Address [1] 326356 0
Country [1] 326356 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321742 0
Women's and Children's Health Network Human Research Ethics Committee
Ethics committee address [1] 321742 0
Ethics committee country [1] 321742 0
Australia
Date submitted for ethics approval [1] 321742 0
04/08/2026
Approval date [1] 321742 0
25/09/2026
Ethics approval number [1] 321742 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 154694 0
Miss Gemma Zanardo
Address 154694 0
Women's and Children's Hospital - Level 1 Rieger Building, 72 King William Road, NORTH ADELAIDE 5006
Country 154694 0
Australia
Phone 154694 0
+61 8 8161 7233
Fax 154694 0
Email 154694 0
Contact person for public queries
Name 154695 0
Gemma Zanardo
Address 154695 0
Women's and Children's Hospital - Level 1 Rieger Building, 72 King William Road, NORTH ADELAIDE 5006
Country 154695 0
Australia
Phone 154695 0
+61 8 8161 7233
Fax 154695 0
Email 154695 0
Contact person for scientific queries
Name 154696 0
Gemma Zanardo
Address 154696 0
Women's and Children's Hospital - Level 1 Rieger Building, 72 King William Road, NORTH ADELAIDE 5006
Country 154696 0
Australia
Phone 154696 0
+61 8 8161 7233
Fax 154696 0
Email 154696 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.